HomeInsightsStock Comparison

Sun Pharmaceutical Industries Ltd vs Wanbury Ltd Stock Comparison

Sun Pharmaceutical Industries Ltd vs Wanbury Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Sun Pharmaceutical Industries Ltd is ₹ 1629 as of 01 Aug 15:30.
  • The P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 38.1 on March 2025 . This represents a CAGR of 9.18% over 6 yearsThe P/E Ratio of Wanbury Ltd changed from 0.7 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 416392 crore on March 2025 . This represents a CAGR of 30.45% over 6 yearsThe Market Cap of Wanbury Ltd changed from ₹ 45.49 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The revenue of Sun Pharmaceutical Industries Ltd for the Jun '25 is ₹ 14315 crore as compare to the Mar '25 revenue of ₹ 13571 crore. This represent the growth of 5.48% The revenue of Wanbury Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 173.84 crore. This represent the decline of -100%.
  • The ebitda of Sun Pharmaceutical Industries Ltd for the Jun '25 is ₹ 3948 crore as compare to the Mar '25 ebitda of ₹ 3967 crore. This represent the decline of -0.48% The ebitda of Wanbury Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 31.47 crore. This represent the decline of -100%.
  • The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2302 crore over 9 quarters. This represents a CAGR of 6.16% The net profit of Wanbury Ltd changed from ₹ 4.69 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 89.64 % on March 2025 . This represents a CAGR of 20.09% over 6 yearsThe Dividend Payout of Wanbury Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

About Wanbury Ltd

  • Wanbury Ltd (Formerly known Pearl Organics Limited) was incorporated in August, 1988.
  • The Company is engaged in the business of pharmaceutical and related activities, including research. The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs.
  • In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga.
  • In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US. In 2007-08, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007.
  • Pursuant to the aforesaid Order of the Hon'ble Bl FR 7,85,557 Equity Shares of face value of Rs. 10/- each of the Company were issued to the Equity Shareholders of DOCL on 17th March, 2008.

Sun Pharmaceutical Industries Ltd News Hub

News

Sun Pharma drops after Q1 PAT slips 20% YoY to Rs 2,279 cr

The drop in profit was primarily due to a one-time exceptional charge of Rs 818 crore duri...

Read more

31 Jul 2025 15:46

News

Sun Pharmaceutical Industries Ltd spurts 0.66%, up for five straight sessions

Sun Pharmaceutical Industries Ltd rose for a fifth straight session today. The stock is qu...

Read more

29 Jul 2025 13:00

News

Sun Pharma announces top-line results of tildrakizumab 100 mg Phase 3 studies

Sun Pharmaceutical Industries announced top-line results from two Phase 3 clinical studies...

Read more

21 Jul 2025 09:05

News

Sun Pharmaceutical Industries Ltd spurts 2.56%, rises for third straight session

Sun Pharmaceutical Industries Ltd rose for a third straight session today. The stock is qu...

Read more

15 Jul 2025 13:05

News

Sun Pharma launches Leqselvi in US; settles litigation with Incyte Corp

The drug is indicated for the treatment of alopecia areata ' a condition in which the immu...

Read more

15 Jul 2025 15:41

News

Sun Pharmaceutical Industries launches LEQSELVI' (deuruxolitinib) 8 mg tablets in United States

Sun Pharmaceutical Industries announced LEQSELVI' (deuruxolitinib) 8 mg tablets is now ava...

Read more

14 Jul 2025 16:48

Wanbury Ltd News Hub

News

Wanbury to hold board meeting

Wanbury will hold a meeting of the Board of Directors of the Company on 4 August 2025. Pow...

Read more

29 Jul 2025 09:47

News

Wanbury's Patalganga facility receives GMP certification from ANVISA

Earlier this month, on 12 May 2025, the company had also received GMP approval from ANVISA...

Read more

20 May 2025 10:09

News

Wanbury spurts after Tanuku facility clears ANVISA inspection with zero observations

The inspection was conducted from 16 December to 20 December 2024, confirmed the facility'...

Read more

12 May 2025 15:25

News

Wanbury announces board meeting date

Wanbury will hold a meeting of the Board of Directors of the Company on 15 May 2025. Power...

Read more

09 May 2025 10:33

News

Wanbury edges higher post conclusion of NCD refinancing at lower rates

The company stated that it has repurchased the entire Rs 95 crore issue of 21% secured NCD...

Read more

06 Mar 2025 12:11

News

Wanbury to declare Quarterly Results

Wanbury will hold a meeting of the Board of Directors of the Company on 12 February 2025. ...

Read more

11 Feb 2025 10:53

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Wanbury Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Sun Pharmaceutical Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Wanbury Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Sun Pharmaceutical Industries Ltd and Wanbury Ltd

Which company has a larger market capitalization, Sun Pharmaceutical Industries Ltd or Wanbury Ltd?

Market cap of Sun Pharmaceutical Industries Ltd is 390,863 Cr while Market cap of Wanbury Ltd is 886 Cr

What are the key factors driving the stock performance of Sun Pharmaceutical Industries Ltd and Wanbury Ltd?

The stock performance of Sun Pharmaceutical Industries Ltd and Wanbury Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sun Pharmaceutical Industries Ltd and Wanbury Ltd?

As of August 2, 2025, the Sun Pharmaceutical Industries Ltd stock price is INR ₹1629.05. On the other hand, Wanbury Ltd stock price is INR ₹269.75.

How do dividend payouts of Sun Pharmaceutical Industries Ltd and Wanbury Ltd compare?

To compare the dividend payouts of Sun Pharmaceutical Industries Ltd and Wanbury Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions